Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9716)
All Articles published online
|
Publishing Process of This Article
|
Nov 7, 2015 (publication date) through Nov 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Fukui H. Do vasopressin V2 receptor antagonists benefit cirrhotics with refractory ascites? World J Gastroenterol 2015; 21(41): 11584-11596 [PMID: 26556988 DOI: 10.3748/wjg.v21.i41.11584] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v21/i41/11584.htm |
| Number | Citing Articles |
| 1 |
Yumi Noda, Sei Sasaki. Updates and Perspectives on Aquaporin-2 and Water Balance Disorders. International Journal of Molecular Sciences 2021; 22(23): 12950 doi: 10.3390/ijms222312950
|
| 2 |
Luis Rodrigo. Ascites - Physiopathology, Treatment, Complications and Prognosis. 2017; doi: 10.5772/intechopen.70232
|
| 3 |
Ioannis Bellos, Konstantinos Kontzoglou, Despina N Perrea. Predictors of tolvaptan short‐term response in patients with refractory ascites: A meta‐analysis. Journal of Gastroenterology and Hepatology 2020; 35(2): 182 doi: 10.1111/jgh.14784
|
| 4 |
Hideto Kawaratani, Hiroshi Fukui, Kei Moriya, Ryuichi Noguchi, Tadashi Namisaki, Masakazu Uejima, Mitsuteru Kitade, Kosuke Takeda, Yasushi Okura, Kosuke Kaji, Norihisa Nishimura, Hiroaki Takaya, Yousuke Aihara, Yasuhiko Sawada, Shinya Sato, Kenichiro Seki, Akira Mitoro, Junichi Yamao, Hitoshi Yoshiji. Predictive parameter of tolvaptan effectiveness in cirrhotic ascites. Hepatology Research 2017; 47(9): 854 doi: 10.1111/hepr.12826
|
| 5 |
Qi Ling, Haojiang Dai, Runzhou Zhuang, Tian Shen, Weilin Wang, Xiao Xu, Shusen Zheng. Predicting short-term survival after liver transplantation on eight score systems: a national report from China Liver Transplant Registry. Scientific Reports 2017; 7(1) doi: 10.1038/srep42253
|
| 6 |
Alessandro Peri, Dario Norello, Benedetta Fibbi. Hydro Saline Metabolism. Endocrinology 2023; : 225 doi: 10.1007/978-3-031-27119-9_8
|
| 7 |
Theodosios D. Filippatos, George Liamis, Moses S. Elisaf. Ten pitfalls in the proper management of patients with hyponatremia. Postgraduate Medicine 2016; 128(5): 516 doi: 10.1080/00325481.2016.1186488
|
| 8 |
Yasuhiko Sawada, Makoto Shiraki, Motoh Iwasa, Atsushi Hiraoka, Hiroyuki Nakanishi, Yoshiyasu Karino, Tomoaki Nakajima, Hisamitsu Miyaaki, Takumi Kawaguchi, Hitoshi Yoshiji, Kiwamu Okita, Kazuhiko Koike. The effects of diuretic use and the presence of ascites on muscle cramps in patients with cirrhosis: a nationwide study. Journal of Gastroenterology 2020; 55(9): 868 doi: 10.1007/s00535-020-01694-8
|
| 9 |
Alessandro Peri, Dario Norello, Benedetta Fibbi. Hydro Saline Metabolism. Endocrinology 2022; : 1 doi: 10.1007/978-3-030-44628-4_8-1
|
| 10 |
Masayuki Miyazaki, Masayoshi Yada, Kosuke Tanaka, Takeshi Senjyu, Takeshi Goya, Kenta Motomura, Motoyuki Kohjima, Masaki Kato, Akihide Masumoto, Kazuhiro Kotoh. Efficacy of tolvaptan for the patients with advanced hepatocellular carcinoma. World Journal of Gastroenterology 2017; 23(29): 5379-5385 doi: 10.3748/wjg.v23.i29.5379
|
| 11 |
Kazuto Tajiri, Yoshiharu Tokimitsu, Hiroyuki Ito, Yoshinari Atarashi, Kengo Kawai, Masami Minemura, Satoshi Yasumura, Terumi Takahara, Yukihiro Shimizu, Toshiro Sugiyama. Survival Benefit of Tolvaptan for Refractory Ascites in Patients with Advanced Cirrhosis. Digestive Diseases 2018; 36(4): 314 doi: 10.1159/000489258
|
| 12 |
Ryo Matsuura, Kent Doi. Critical Care Nephrology. 2019; : 364 doi: 10.1016/B978-0-323-44942-7.00062-5
|
| 13 |
E. Sbardella, A. M. Isidori, G. Arnaldi, M. Arosio, C. Barone, A. Benso, R. Berardi, G. Capasso, M. Caprio, F. Ceccato, G. Corona, S. Della Casa, L. De Nicola, M. Faustini-Fustini, E. Fiaccadori, L. Gesualdo, S. Gori, A. Lania, G. Mantovani, P. Menè, G. Parenti, C. Pinto, R. Pivonello, P. Razzore, G. Regolisti, C. Scaroni, F. Trepiccione, A. Lenzi, A. Peri. Approach to hyponatremia according to the clinical setting: Consensus statement from the Italian Society of Endocrinology (SIE), Italian Society of Nephrology (SIN), and Italian Association of Medical Oncology (AIOM). Journal of Endocrinological Investigation 2018; 41(1): 3 doi: 10.1007/s40618-017-0776-x
|
| 14 |
Carlos G. Musso, Rossina Juarez, Richard J. Glassock. Water, electrolyte, acid–base, and trace elements alterations in cirrhotic patients. International Urology and Nephrology 2018; 50(1): 81 doi: 10.1007/s11255-017-1614-y
|
| 15 |
Beata Kasztelan-Szczerbinska, Halina Cichoz-Lach. Refractory ascites—the contemporary view on pathogenesis and therapy. PeerJ 2019; 7: e7855 doi: 10.7717/peerj.7855
|
| 16 |
David C. Madoff, Joshua Cornman-Homonoff, Brett E. Fortune, Ron C. Gaba, Andrew J. Lipnik, Hooman Yarmohammadi, Charles E. Ray. Management of Refractory Ascites Due to Portal Hypertension: Current Status. Radiology 2021; 298(3): 493 doi: 10.1148/radiol.2021201960
|
| 17 |
Takefumi Mori, Yusuke Ohsaki, Ikuko Oba‐Yabana, Sadayoshi Ito. Diuretic usage for protection against end‐organ damage in liver cirrhosis and heart failure. Hepatology Research 2017; 47(1): 11 doi: 10.1111/hepr.12700
|
| 18 |
Hideto Kawaratani, Hiroshi Fukui, Hitoshi Yoshiji. Treatment for cirrhotic ascites. Hepatology Research 2017; 47(2): 166 doi: 10.1111/hepr.12769
|